Development of a validated immunofluorescence assay for γH2AX as a pharmacodynamic marker of topoisomerase I inhibitor activity (Q34316288)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Development of a validated immunofluorescence assay for γH2AX as a pharmacodynamic marker of topoisomerase I inhibitor activity
scientific article

    Statements

    Development of a validated immunofluorescence assay for γH2AX as a pharmacodynamic marker of topoisomerase I inhibitor activity (English)
    Robert J Kinders
    Melinda Hollingshead
    Scott Lawrence
    William M Bonner
    Larry Rubinstein
    Yvonne A Evrard
    Ralph E Parchment
    Joseph Tomaszewski
    James H Doroshow
    National Cancer Institute Phase 0 Clinical Trials Team
    5 October 2010
    5447-5457

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit